The Medical Center at Franklin has enhanced its diagnostic imaging capabilities with the addition of 3D mammography. Utilizing advanced breast tomosynthesis technology, Genius™ 3D Mammography™ exams, developed by Hologic, Inc., are clinically proven to significantly increase the detection of breast cancers, and also decrease the number of women asked to return for additional testing. The Hologic system is the first FDA-approved breast tomosynthesis system in the U.S.
In conventional 2D mammography, overlapping tissue is a leading reason why small breast cancers may be missed and normal tissue may appear abnormal, leading to unnecessary callbacks. A three-dimensional method of imaging can greatly reduce the tissue overlap effect.
A Genius exam includes both 2D images and tomosynthesis scans which take multiple images. A computer then converts the images into a stack of thin layers, allowing the radiologist to review the breast tissue one layer at a time. The exam requires no additional compression and takes just a few seconds longer than a conventional 2D breast cancer screening exam.
3D mammography revolutionizes how breast cancer is detected by providing a better option for women of all breast densities compared to 2D alone. With the Genius™ 3D Mammography™ exam, researchers have found that:
- 20-65% more invasive breast cancers are found compared to 2D alone, an average increase of 41%
- 3D mammography is superior for women with dense breasts compared to 2D alone
- Callbacks are reduced by up to 40% compared to 2D alone
“The Medical Center at Franklin is committed to using best practice to help detect and fight breast cancer,” says Annette Runyon, Vice President and Administrator of The Medical Center at Franklin. “In offering this new 3D technology, The Medical Center at Franklin provides a more accurate tool for breast cancer screening that will help save more lives.”